Loading data
ANNXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 184.7 m USD | 119.45 m USD | 113.76 m USD | 112.5 m USD | 100.07 m USD |
| Operating profit | -216.41 m USD | -154.07 m USD | -143.72 m USD | -145.6 m USD | -130.71 m USD |
| Profit before tax | -206.69 m USD | -138.2 m USD | 134.24 m USD | 141.95 m USD | 130.32 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | — |
| Net income (reported basis) | -206.7 m USD | -138.2 m USD | -134.2 m USD | -142 m USD | -130.32 m USD |
| Net income attributable to common shareholders | -208.55 m USD | -138.2 m USD | — | -141.95 m USD | -130.32 m USD |
| Basic earnings per share | -1.34 USD/share | -1.01 USD/share | -1.77 USD/share | -2.6 USD/share | -3.4 USD/share |
| Diluted earnings per share | -1.34 USD/share | -1.01 USD/share | -1.77 USD/share | -2.6 USD/share | -3.4 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.